BioPharmaDispatch | BioPharmaDispatch
The chief executive of Medicines Australia discusses the health technology assessment review, where she is now a member of its reference committee, the association's objectives and what the government might want from the process.
By using our site, you acknowledge that you have read and understand our Privacy Policy, and our Terms of Service.